InsidersTradesSigma
Follow the Egetis Therapeutics AB (publ) share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Egetis Therapeutics AB (publ) has published 28 public disclosures. Market capitalisation: €3.7bn. The latest transaction was reported on 3 September 2026 (Purchase). Among the most active insiders: Christian Sonesson. All data is accessible without an account.
28
Insider Decl.
n/a
Thresholds
€52,213
19 ops.
Buy Volume
€842,189
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Egetis Therapeutics AB (publ) Buy (bullish), based on 3 analysts. Average price target: SEK 15.33.
34Σ signal
Fundamental score
Ranked 27,595 of 29,062 companies
15.9
score / 100
Value18
Quality14
FCF yld-7.2%
Earn yld-9.2%
EV/EBITDA·
ROE-97%
Gross mgn20%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
Declarations28 total
1,099 shares0AktieISIN SE0003815604FI:csv-24e02d5ee31cbbc703d2
1,099 shares0AktieISIN SE0003815604FI:csv-87582a6f9181baf68618
594 shares@ SEK 7.7719AktieISIN SE0003815604FI:csv-7bfe64144f561ff8f691
1,099 shares0AktieISIN SE0003815604FI:csv-49cfae9c437db1777dba
2,198 shares0AktieISIN SE0003815604FI:csv-52c25c2a4067c0f7ea17
158,928 shares@ SEK 6.500.036% mcap48.3% of flowAktieISIN SE0003815604FI:csv-2095cc230f6097f680ca
264,880 shares0AktieISIN SE0003815604FI:csv-175d73b1ea8853239cdb
37,202 shares0AktieISIN SE0003815604FI:csv-e9e8616ad9038e8953be
158,928 shares@ SEK 6.500.033% mcap93.6% of flowAktieISIN SE0017770027FI:csv-f87ec71e64a442ce7e24
264,880 shares0AktieISIN SE0003815604FI:csv-1ef0079ec6f2384808c5
286,071 shares@ SEK 6.500.059% mcap100.0% of flowAktieISIN SE0003815604FI:csv-080acb505ed56ada1bf4
529,761 shares0AktieISIN SE0003815604FI:csv-841ca189a7c635e1917d
529,761 shares0AktieISIN SE0003815604FI:A003Y632-1
264,880 shares0AktieISIN SE0003815604FI:A003Y653-1
264,880 shares@ SEK 6.500.054% mcap94.6% of flowAktieISIN SE0003815604FI:csv-4f6c60d76c6f9c961f8e
264,880 shares0AktieISIN SE0003815604FI:csv-5062421e5700a2577d48
264,880 shares0AktieISIN SE0003815604FI:A003Y615-1
119,529 shares@ SEK 6.500.024% mcap46.5% of flowAktieISIN SE0003815604FI:csv-6bcea8f583b1cb375000
265,620 shares0AktieISIN SE0003815604FI:csv-c81607ca7a4dc540e585
153,631 shares@ SEK 6.500.031% mcap44.8% of flowAktieISIN SE0003815604FI:csv-fd45067293b119868f0a
264,880 shares0AktieISIN SE0003815604FI:csv-20298035c5d4dc97dbf5
153,631 shares@ SEK 6.500.031% mcap81.3% of flowAktieISIN SE0003815604FI:A003Y582-1
119,529 shares@ €0.59480.024% mcap86.9% of flowAktieISIN SE0003815604FI:A003Y593-1
60,000 shares@ €0.35090.0073% mcap18.7% of flowAktieISIN SE0003815604FI:A003U276-2
25,000 shares@ €0.43030.0037% mcap13.1% of flowAktieISIN SE0003815604FI:A003U284-1
25 of 28 declarations
关于 Egetis Therapeutics AB (publ)
Egetis Therapeutics AB (publ) 是一家瑞典生物制药公司，专注于开发罕见疾病治疗方法。该公司在斯德哥尔摩证券交易所 (XSTO) 上市。
